ResMed Inc. vs. Neuronetics, Inc. Common Stock
ResMed Inc. (RMD) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| RMD | STIM | |
|---|---|---|
| Market Cap | $34.13 billion | $227.07 million |
| Revenue (TTM) | $5.65 billion | — |
| Net Income (TTM) | $1.52 billion | — |
RMD leads on 1 of 1 size & scale factors.
Valuation
| RMD | STIM | |
|---|---|---|
| P/E Ratio | 22.60 | — |
| Price / Book | 5.18 | 10.49 |
| Price / Sales | 6.04 | — |
RMD leads on 1 of 1 valuation factors.
Profitability
| RMD | STIM | |
|---|---|---|
| Net Margin | 26.94% | — |
| Return on Equity | 23.13% | — |
RMD and STIM split the profitability factors evenly.
Dividend
| RMD | STIM | |
|---|---|---|
| Dividend Yield | 1.12% | — |
| Payout Ratio | 25.31 | — |
RMD and STIM split the dividend factors evenly.
Risk & Sentiment
| RMD | STIM | |
|---|---|---|
| Short Interest | 4.04% | 0.01% |
STIM leads on 1 of 1 risk & sentiment factors.
Dig deeper: RMD overview, RMD financials, STIM overview, STIM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.